"","Cites","Authors","Title","Year","Source","Publisher","ArticleURL","CitesURL","GSRank","QueryDate","Type","DOI","ISSN","CitationURL","Volume","Issue","StartPage","EndPage","ECC","CitesPerYear","CitesPerAuthor","AuthorCount","Age","Abstract","generic_drug_name"
"1",16,"C.E. Morris","Left-shifted Nav channels in injured bilayer: Primary targets for neuroprotective Nav antagonists?",2012,"Frontiers in Pharmacology",NA,"https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84864842078&origin=inward","https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84864842078&origin=inward",1,"2021-01-15 16:23:31","Article","10.3389/fphar.2012.00019","1663-9812","https://api.elsevier.com/content/abstract/scopus_id/84864842078",3,NA,NA,NA,16,1.78,16,1,9,NA,"ranolazine"
